Outcomes of Intravesical Bacillus Calmette-Guerin (BCG) in patients with Non-Muscle Invasive Bladder Cancer: A retrospective study in Australia

被引:0
|
作者
Pillippuhewa, Chamodi [1 ]
Della-Fiorentina, Stephen [1 ,2 ,3 ]
Haghighi, Kayvan [4 ,5 ]
Chau, Wei [6 ,7 ]
Kok, Peey-Sei [1 ,8 ]
机构
[1] Western Sydney Univ, Penrith, NSW, Australia
[2] Southern Highlands Canc Ctr, Bowral, NSW, Australia
[3] Campbelltown Hosp, Macarthur Canc Therapy Clin, Greater Western Sydney, NSW, Australia
[4] Campbelltown Private Hosp, Macarthur Urol, Greater Western Sydney, NSW, Australia
[5] Campbelltown Hosp, Dept Urol, Greater Western Sydney, NSW, Australia
[6] Liverpool Hosp, Liverpool Canc Therapy Ctr, Greater Western Sydney, NSW, Australia
[7] Univ New South Wales, Sydney, NSW, Australia
[8] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
abs38
引用
收藏
页码:61 / 61
页数:1
相关论文
共 50 条
  • [31] A MULTI-INSTITUTIONAL ANALYSIS OF PATIENT OUTCOMES FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Sangster, Pippa
    Symes, Andrew
    Walker, Roger
    Morley, Roland
    Thompson, Alan
    Dick, John
    Le Roux, Peter
    Sandhu, Sarb
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E524 - E524
  • [32] Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review
    Saluja, Manmeet
    Gilling, Peter
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (01) : 18 - 24
  • [33] Is the role of intravesical bacillus Calmette-Guerin in non-muscle-invasive bladder cancer changing?
    Ayres, Benjamin E.
    Griffiths, T. R. Leyshon
    Persad, Raj A.
    [J]. BJU INTERNATIONAL, 2010, 105 : 8 - 13
  • [34] Intravesical docetaxel for high-risk non-muscle invasive bladder cancer after Bacillus Calmette-Guerin failure
    Shantharam, Govind
    Amin, Ali
    Pereira, Jorge
    Kott, Ohad
    Mueller-Leonhard, Catrina
    Mega, Anthony
    Golijanin, Dragan
    Gershman, Boris
    [J]. CURRENT UROLOGY, 2021, 15 (01) : 33 - 38
  • [35] Effect of intravesical Bacillus Calmette-Guerin (BCG) induction therapy on sperm parameters in sexually active male patients diagnosed with non-muscle invasive bladder cancer
    Sahin, S.
    Canitez, I. O.
    Dusunus, Y. E.
    Yentur, S.
    Ulus, I
    Temiz, M. Z.
    Semercioz, A.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S1186 - S1186
  • [36] Methylation status as a predictor of intravesical Bacillus Calmette-Guerin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor
    Husek, Petr
    Pacovsky, Jaroslav
    Chmelarova, Marcela
    Podhola, Miroslav
    Brodak, Milos
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (02): : 210 - 216
  • [37] Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule
    Kanuj Malik
    Anand Raja
    Lalgudi Subramaniam Ravishankar
    Kathiresan Narayanaswamy
    Venkatraman Radhakrishnan
    Tenali Gnana Sagar
    [J]. Indian Journal of Surgical Oncology, 2021, 12 : 796 - 801
  • [38] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    [J]. CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [39] Bacillus Calmette-Guerin (BCG) and alternatives Drug treatment of high-risk non-muscle invasive bladder cancer
    Leucht, K.
    Foller, S.
    Grimm, Marc-Oliver
    [J]. UROLOGE, 2021, 60 (11): : 1400 - 1408
  • [40] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Uchio, E.
    Steinberg, G. D.
    Shore, N.
    Anderson, P. D.
    Ben, T.
    Kamat, A.
    Keel, M.
    Packiam, V.
    McAdory, J.
    Kim, J. H.
    Chisamore, M.
    Grandi, P.
    Burke, J.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A130